Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma. Nakagawa S, Miyashita M, Maeda I, Goda A, et al. Breast Cancer Res Treat 2024 Jan 5. doi: 10.1007/s10549-023-07209.

Read + Share

Amedeo Smart

Independent Medical Education

Nakagawa S, Miyashita M, Maeda I, Goda A, et al. Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma. Breast Cancer Res Treat 2024 Jan 5. doi: 10.1007/s10549-023-07209.
PMID: 38180699